Early Access — free while we kick the tires
EdgarHawk

Masoud Maher

President and CEO

Director Officer
1 filing analyzed · 1 company · Latest 2025-08-13

Companies

Company Buys Sells Direction
MAXCYTE, INC. MXCT 1 0 Net buying

Activity

August 2025
2025-08-13 MAXCYTE, INC. MXCT
high
Buy
75,000 shares
$102,915
Significance 6/10

MXCT CEO Masoud Maher bought 75,000 shares at $1.37 (Aug 13); stock down 72.9% from 52-week high, cluster of 4 other insider buys in 14 days

Masoud Maher, President and CEO, purchased 75,000 shares at $1.37 on 2025-08-13, increasing his holdings from 100,000 to 175,000 shares (75.0% increase). The transaction occurs against a severely depressed price backdrop: the stock trades at $1.38 today, -72.9% from the 52-week high of $5.10, and down -38.4% over the past 30 days. At the same-ticker level, Maher's two prior purchases in June 2024 delivered negative returns at both the 30-day and 90-day horizons, with 0 of 2 buys proving well-timed at the 90-day mark. The company fundamentals are challenging: latest quarterly revenue is $8.5M with a net loss of $-12.4M; annual revenue declined -6.4% year-over-year, and the firm was unprofitable over the most recent full fiscal year. Notably, 4 other insiders also purchased shares within the past 14 days, creating a cluster buy pattern. This synchronized buying by multiple insiders at extreme lows, combined with Maher's poor historical timing at this specific ticker and the company's negative earnings and declining revenue, presents a factual pattern warranting investor scrutiny of the underlying rationale.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access